GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » P&K Skin Research Center Co Ltd (XKRX:347740) » Definitions » YoY EBITDA Growth

P&K Skin Research Center Co (XKRX:347740) YoY EBITDA Growth : 9.15% (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is P&K Skin Research Center Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. P&K Skin Research Center Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was 9.15%.

P&K Skin Research Center Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩73.45.


P&K Skin Research Center Co YoY EBITDA Growth Historical Data

The historical data trend for P&K Skin Research Center Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

P&K Skin Research Center Co YoY EBITDA Growth Chart

P&K Skin Research Center Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
Get a 7-Day Free Trial -73.87 13.32 -75.27 292.19 -27.04

P&K Skin Research Center Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 309.41 67.82 -36.68 -19.23 9.15

P&K Skin Research Center Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

P&K Skin Research Center Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(236.834-324.621)/ | 324.621 |
=-27.04 %

P&K Skin Research Center Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(73.45-67.294)/ | 67.294 |
=9.15 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


P&K Skin Research Center Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of P&K Skin Research Center Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


P&K Skin Research Center Co (XKRX:347740) Business Description

Traded in Other Exchanges
N/A
Address
National Assembly Road 62 -25 Yeongdeungpo-gu, Education Facility Disaster Relief Society Building, 4th Floor, Seoul, KOR, 07236
P&K Skin Research Center Co Ltd is a skin research center. It provides clinical tests for new cosmetics, raw materials, and cosmeceuticals. The company provides skin irritation tests, Stimulation tests, skin wrinkle evaluation, skin texture evaluation, skin whitening evaluation, sweat proof evaluation, skin density measurement, scalp flakiness evaluation, and hair root evaluation. Also, the company provides health food tests, sensory tests, and In Vitro tests.

P&K Skin Research Center Co (XKRX:347740) Headlines

No Headlines